Imdelltra 10 mg lyophilized powder for injection Images
Generic Name: tarlatamab
This medication has been identified as Imdelltra 10 mg lyophilized powder for injection. It is supplied by Amgen Inc.
Imdelltra is used in the treatment of Small Cell Lung Cancer and belongs to the drug class bispecific T-cell engagers (BiTE). Imdelltra 10 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Imdelltra
- Generic Name
- tarlatamab
- Strength
- 10 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Bispecific T-cell engagers (BiTE)
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amgen Inc.
- National Drug Code (NDC)
- 55513-0077
More about Imdelltra (tarlatamab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bispecific T-cell engagers (BiTE)
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.